Literature DB >> 6712861

The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.

R G Wilcox, T Bennett, I A Macdonald, M Herbert, A M Skene.   

Abstract

We have studied the physiological responses to 50 min of intermittent, moderate exercise in hypertensive men after the ingestion of a single dose of placebo, propranolol or metoprolol, and also after 28 days treatment. In addition, subjective assessments of mood were made during the last 7 days of each period of chronic treatment. Heart rate and blood pressure, both at rest and during exercise, were significantly reduced by a single dose of propranolol or metoprolol; more marked effects were observed after chronic treatment. Ventilation and gas exchange during exercise were only slightly disturbed by single doses of propranolol or metoprolol, whereas chronic treatment had no effect. Perceived exertion scores were increased after a single dose of either drug, compared to placebo, and the effect of propranolol was greater than that of metoprolol. With chronic treatment there were fewer differences between the perceived exertion scores during exercise, although 'leg' fatigue remained greater after propranolol than after placebo. Sweating from the forehead during exercise was enhanced by a single dose of either beta-adrenoceptor antagonist, with propranolol having the greater effect. After chronic treatment the effect of propranolol was diminished, whereas the effect of metoprolol was maintained. Very few disturbances of mood were found after chronic ingestion of the beta-adrenoceptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712861      PMCID: PMC1463373          DOI: 10.1111/j.1365-2125.1984.tb02342.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

2.  Propranolol enhancement of hypoglycemic sweating.

Authors:  G W Molnar; R C Read
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

3.  Effects of atropine and propranolol on the oxygen transport system during exercise in man.

Authors:  B Ekblom; A N Goldbarg; A Kilbom; P O Astrand
Journal:  Scand J Clin Lab Invest       Date:  1972-09       Impact factor: 1.713

4.  Effects of propranolol on the response of human eccrine sweat glands to acetylcholine.

Authors:  K G Foster; J R Haspineall; C L Mollel
Journal:  Br J Dermatol       Date:  1971-10       Impact factor: 9.302

5.  An instrument for estimating evaporation from small skin surfaces.

Authors:  L O Lamke
Journal:  Scand J Plast Reconstr Surg       Date:  1970

6.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

7.  Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.

Authors:  S Epstein; B F Robinson; R L Kahler; E Braunwald
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

8.  Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.

Authors:  B Ablad; E Carlsson; L Ek
Journal:  Life Sci I       Date:  1973-02-01

9.  Patient acceptability of propranolol and the occurence of side effects.

Authors:  F J Zacharias
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

10.  Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.

Authors:  G Leonetti; G Mayer; A Morganti; L Terzoli; A Zanchetti; G Bianchetti; E Di Salle; P L Morselli; C A Chidsey
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06
View more
  18 in total

1.  Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones.

Authors:  D Kerr; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

2.  A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.

Authors:  M Ligueros; R Unwin; M R Wilkins; J Humphreys; S J Coles; J Cleland
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

3.  β-Adrenergic receptor blockade does not modify non-thermal sweating during static exercise and following muscle ischemia in habitually trained individuals.

Authors:  Tatsuro Amano; Anna Igarashi; Naoto Fujii; Daichi Hiramatsu; Yoshimitsu Inoue; Narihiko Kondo
Journal:  Eur J Appl Physiol       Date:  2018-09-20       Impact factor: 3.078

Review 4.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 5.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

Review 6.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 7.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

8.  Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.

Authors:  W E Derman; F Dunbar; M Haus; M Lambert; T D Noakes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

9.  Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes.

Authors:  D Kerr; I A Macdonald; S R Heller; R B Tattersall
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

10.  Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.

Authors:  R G Wilcox; T Bennett; I A Macdonald; F Broughton Pipkin; P H Baylis
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.